A selected Lactobacillus rhamnosus strain promotes EGFR-independent Akt activation in an enterotoxigenic Escherichia coli K88-infected IPEC-J2 cell model

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Zhang, Wei ^a   Zhu, Yao Hong ^a   Yang, Jin Cai ^a   Yang, Gui Yan ^a   Zhou, Dong ^a   Wang, Jiu Feng ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; OCCLUDIN; PROTEIN KINASE B; PROTEIN ZO1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; EPIDERMAL GROWTH FACTOR; MUCIN; ONCOPROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME ACTIVATION; INCUBATION TIME; INTESTINE EPITHELIUM CELL; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; ANIMAL; BACTERIUM ADHERENCE; CELL LINE; ESCHERICHIA COLI INFECTION; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOBACILLUS RHAMNOSUS; SUS;

ANIMALS; APOPTOSIS; BACTERIAL ADHESION; BLOTTING, WESTERN; CELL LINE; ENTEROTOXIGENIC ESCHERICHIA COLI; EPIDERMAL GROWTH FACTOR; ESCHERICHIA COLI INFECTIONS; INTESTINAL MUCOSA; LACTOBACILLUS RHAMNOSUS; MUCINS; NOD2 SIGNALING ADAPTOR PROTEIN; ONCOGENE PROTEIN V-AKT; REAL-TIME POLYMERASE CHAIN REACTION; SWINE; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928534091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125717     Document Type: Article

References (57)

1. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010; 8: 26-38. doi: 10.1038/nrmicro2265 PMID: 19966814
2. Fairbrother JM, Nadeau É, Gyles CL. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim Health Res Rev. 2007; 6: 17-39.
3. Li XQ, Zhu YH, Zhang HF, Yue Y, Cai ZX, Lu QP, et al. Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances. PLoS One. 2012; 7: e40666. doi: 10.1371/journal.pone.0040666 PMID: 22848393
4. Zhang L, Xu YQ, Liu HY, Lai T, Ma JL, Wang JF, et al. Evaluation of Lactobacillus rhamnosus GG using an Escherichia coli K88 model of piglet diarrhoea: effects on diarrhoea incidence, faecal microflora and immune responses. Vet Microbiol. 2010; 141: 142-148. doi: 10.1016/j.vetmic.2009.09.003 PMID: 19782483
5. Zhu YH, Li XQ, Zhang W, Zhou D, Liu HY, Wang JF. Dose-dependent effects of Lactobacillus rhamnosus on serum interleukin-17 production and intestinal T-Cell responses in pigs challenged with Escherichia coli. Appl Environ Microbiol. 2014; 80: 1787-1798. doi: 10.1128/AEM.03668-13 PMID: 24389928
6. Kleta S, Nordhoff M, Tedin K, Wieler LH, Kolenda R, Oswald S, et al. Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection. Infect Immun. 2014; 82: 1801-1812. doi: 10.1128/IAI.01431-13 PMID: 24549324
7. Finamore A, Roselli M, Imbinto A, Seeboth J, Oswald IP, Mengheri E. Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explants. PLoS One. 2014; 9: e94891. doi: 10.1371/journal.pone.0094891 PMID: 24733511
8. Orlando A, Linsalata M, Notarnicola M, Tutino V, Russo F. Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines. BMC Microbiol. 2014; 14: 19. doi: 10.1186/1471-2180-14-19 PMID: 24483336
9. Johansson ME, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013; 10: 352-361. doi: 10.1038/nrgastro.2013.35 PMID: 23478383
10. Kumar P, Luo Q, Vickers TJ, Sheikh A, Lewis WG, Fleckenstein JM. EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin. Infect Immun. 2014; 82: 500-508. doi: 10.1128/IAI.01078-13 PMID: 24478066
11. Chu H, Mazmanian SK. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol. 2013; 14: 668-675. doi: 10.1038/ni.2635 PMID: 23778794
12. Maisonneuve C, Bertholet S, Philpott DJ, De Gregorio E. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants. Proc Natl Acad Sci U S A. 2014; 111: 12294-12299. doi: 10.1073/pnas.1400478111 PMID: 25136133
13. Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013; 182: 375-387. doi: 10.1016/j.ajpath.2012.10.014 PMID: 23201091
14. Oppong GO, Rapsinski GJ, Newman TN, Nishimori JH, Biesecker SG, Tukel C. Epithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar Typhimurium curli fibrils in the gut. Infect Immun. 2013; 81: 478-486. doi: 10.1128/IAI.00453-12 PMID: 23208603
15. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009; 9: 799-809. doi: 10.1038/nri2653 PMID: 19855405
16. Mathias A, Duc M, Favre L, Benyacoub J, Blum S, Corthesy B. Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA. J Biol Chem. 2010; 285: 33906-33913. doi: 10.1074/jbc.M110.135111 PMID: 20729211
17. Yang K, Jiang Z, Zheng C, Wang L, Yang X. Effect of Lactobacillus plantarum on diarrhea and intestinal barrier function of young piglets challenged with enterotoxigenic Escherichia coli K88. J Anim Sci. 2014; 92: 1496-1503. doi: 10.2527/jas.2013-6619 PMID: 24492550
18. Avraham R, Yarden Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol. 2011; 12: 104-117. doi: 10.1038/nrm3048 PMID: 21252999
19. Banck MS, Kanwar R, Kulkarni AA, Boora GK, Metge F, Kipp BR, et al. The genomic landscape of small intestine neuroendocrine tumors. J Clin Invest. 2013; 123: 2502-2508. doi: 10.1172/JCI67963 PMID: 23676460
20. Yan F, Liu L, Dempsey PJ, Tsai YH, Raines EW, Wilson CL, et al. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor. J Biol Chem. 2013; 288: 30742-30751. doi: 10.1074/jbc.M113.492397 PMID: 24043629
21. Seo GS, Jiang WY, Park PH, Sohn DH, Cheon JH, Lee SH. Hirsutenone reduces deterioration of tight junction proteins through EGFR/Akt and ERK1/2 pathway both converging to HO-1 induction. Biochem Pharmacol. 2014; 90: 115-125. doi: 10.1016/j.bcp.2014.05.006 PMID: 24853984
22. Prince T, McBain AJ, O'Neill CA. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion. Appl Environ Microbiol. 2012; 78: 5119-5126. doi: 10.1128/AEM.00595-12 PMID: 22582077
23. Dharmani P, Srivastava V, Kissoon-Singh V, Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun. 2009; 1: 123-135. doi: 10.1159/000163037 PMID: 20375571
24. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 2003; 52: 827-833. PMID: 12740338
25. Pan Q, Tian Y, Li X, Ye J, Liu Y, Song L, et al. Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved TFLK motif inhibits bacteria adherence. J Biol Chem. 2013; 288: 5407-5416. doi: 10.1074/jbc.M112.408245 PMID: 23316049
26. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc Natl Acad Sci U S A. 2009; 106: 17193-17198. doi: 10.1073/pnas.0908876106 PMID: 19805152
27. Jensen H, Roos S, Jonsson H, Rud I, Grimmer S, van Pijkeren JP, et al. Role of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro. Microbiology. 2014; 160: 671-681. doi: 10.1099/mic.0.073551-0 PMID: 24473252
28. Chen XY, Woodward A, Zijlstra RT, Ganzle MG. Exopolysaccharides synthesized by Lactobacillus reuteri protect against enterotoxigenic Escherichia coli in piglets. Appl Environ Microbiol. 2014; 80: 5752-5760. doi: 10.1128/AEM.01782-14 PMID: 25015886
29. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003; 52: 988-997. PMID: 12801956
30. Lebeer S, Verhoeven TL, Perea Velez M, Vanderleyden J, De Keersmaecker SC. Impact of environmental and genetic factors on biofilm formation by the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol. 2007; 73: 6768-6775. PMID: 17827316
31. Rieu A, Aoudia N, Jego G, Chluba J, Yousfi N, Briandet R, et al. The biofilm mode of life boosts the antiinflammatory properties of Lactobacillus. Cell Microbiol. 2014; 16: 1836-1853. doi: 10.1111/cmi.12331 PMID: 25052472
32. Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol. 2013; 133: 988-998. doi: 10.1038/jid.2012.437 PMID: 23223142
33. Ey B, Eyking A, Klepak M, Salzman NH, Gothert JR, Runzi M, et al. Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis. J Immunol. 2013; 190: 5676-5688. doi: 10.4049/jimmunol.1201592 PMID: 23636052
34. Gibson DL, Ma C, Rosenberger CM, Bergstrom KSB, Valdez Y, Huang JT, et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol. 2007; 10: 388-403. PMID: 17910742
35. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer R-JM, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010; 298: G851-G859. doi: 10.1152/ajpgi.00327.2009 PMID: 20224007
36. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007; 7: 179-190. PMID: 17318230
37. Clarke TB, Francella N, Huegel A, Weiser JN. Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe. 2011; 9: 404-414. doi: 10.1016/j.chom.2011.04.012 PMID: 21575911
38. McLamb BL, Gibson AJ, Overman EL, Stahl C, Moeser AJ. Early weaning stress in pigs impairs innate mucosal immune responses to enterotoxigenic E. coli challenge and exacerbates intestinal injury and clinical disease. PLoS One. 2013; 8: e59838. doi: 10.1371/journal.pone.0059838 PMID: 23637741
39. Ngendahayo Mukiza C, Dubreuil JD. Escherichia coli heat-stable toxin b impairs intestinal epithelial barrier function by altering tight junction proteins. Infect Immun. 2013; 81: 2819-2827. doi: 10.1128/IAI.00455-13 PMID: 23716609
40. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007; 132: 1359-1374. PMID: 17408640
41. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006; 7: 1250-1257. PMID: 17110941
42. Kim JG, Lee SJ, Kagnoff MF. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by Toll-like receptors. Infect Immun. 2004; 72: 1487-1495. PMID: 14977954
43. Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol. 2012; 24: 398-404. doi: 10.1016/j.coi.2012.04.010 PMID: 22677577
44. Corr SC, Palsson-McDermott EM, Grishina I, Barry SP, Aviello G, Bernard NJ, et al. MyD88 adaptorlike (Mal) functions in the epithelial barrier and contributes to intestinal integrity via protein kinase C. Mucosal Immunol. 2014; 7: 57-67. doi: 10.1038/mi.2013.24 PMID: 23612054
45. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004; 127: 224-238. PMID: 15236188
46. Seth A, Yan F, Polk DB, Rao RK. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G1060-1069. doi: 10.1152/ajpgi.00202.2007 PMID: 18292183
47. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol. 2007; 9: 804-816. PMID: 17087734
48. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, et al. Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology. 2009; 136: 1297-1307. doi: 10.1053/j.gastro.2008.12.059 PMID: 19250983
49. Roxas JL, Koutsouris A, Viswanathan VK. Enteropathogenic Escherichia coli-induced epidermal growth factor receptor activation contributes to physiological alterations in intestinal epithelial cells. Infect Immun. 2007; 75: 2316-2324. PMID: 17339360
50. Jamora C, DasGupta R, Kocieniewski P, Fuchs E. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature. 2003; 422: 317-322. PMID: 12646922
51. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, et al. Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling and is important for proliferation and apoptosis in response to intestinal mucosal injury. Gastroenterology. 2006; 131: 862-877. PMID: 16952555
52. Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, Schmitz F. Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr Cancer. 2009; 61: 103-113. doi: 10.1080/01635580802372625 PMID: 19116880
53. Shimazu T, Villena J, Tohno M, Fujie H, Hosoya S, Shimosato T, et al. Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infect Immun. 2012; 80: 276-288. doi: 10.1128/IAI.05729-11 PMID: 22083706
54. Gribar SC, Sodhi CP, Richardson WM, Anand RJ, Gittes GK, Branca MF, et al. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol. 2009; 182: 636-646. PMID: 19109197
55. Dey I, Lejeune M, Chadee K. Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol. 2006; 149: 611-623. PMID: 17016496
56. Wang L, Cao H, Liu L, Wang B, Walker WA, Acra SA, et al. Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG-derived protein. J Biol Chem. 2014; 289: 20234-20244. doi: 10.1074/jbc.M114.553800 PMID: 24895124
57. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest. 2011; 121: 2242-2253. doi: 10.1172/JCI44031 PMID: 21606592